Clinical Trial Update: Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial evaluated whether quercetin, a nutritional supplement, can modulate cerebral blood flow; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Quercetin (quercetin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Stroke, Problem of Aging | EARLY_Phase 1 | Status: COMPLETED